Cargando…

Reinfection and reactivation of SARS-CoV-2

As the cases of SARS-CoV-2 infection escalates, the essence of in-depth knowledge around acquired immunity and emergence of reinfection and reactivation have to be captured. While being a rare phenomenon, reinfection occurs as the result of diminishing protection conferred by antibodies, especially...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowran, Razieh, Damavandi, Amirmasoud Rayati, Azad, Talat Mokhtari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514089/
https://www.ncbi.nlm.nih.gov/pubmed/36176508
http://dx.doi.org/10.2217/fvl-2021-0212
_version_ 1784798202977845248
author Dowran, Razieh
Damavandi, Amirmasoud Rayati
Azad, Talat Mokhtari
author_facet Dowran, Razieh
Damavandi, Amirmasoud Rayati
Azad, Talat Mokhtari
author_sort Dowran, Razieh
collection PubMed
description As the cases of SARS-CoV-2 infection escalates, the essence of in-depth knowledge around acquired immunity and emergence of reinfection and reactivation have to be captured. While being a rare phenomenon, reinfection occurs as the result of diminishing protection conferred by antibodies, especially IgG. Reactivation is more concerned with the role of various elements including shedding lingering viral RNA for a prolonged time and incomplete resolution of infection along with the insight of dormant viral exosomes’ role. The concept of testing positive after two consecutive negative results requires proper discrimination of reinfection from reactivation. In this review, we summarized the current evidence for possible mechanisms leading to viral reactivation or test re-positivity. We also pointed out risk factors associated with both reinfection and reactivation.
format Online
Article
Text
id pubmed-9514089
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-95140892022-09-27 Reinfection and reactivation of SARS-CoV-2 Dowran, Razieh Damavandi, Amirmasoud Rayati Azad, Talat Mokhtari Future Virol Review As the cases of SARS-CoV-2 infection escalates, the essence of in-depth knowledge around acquired immunity and emergence of reinfection and reactivation have to be captured. While being a rare phenomenon, reinfection occurs as the result of diminishing protection conferred by antibodies, especially IgG. Reactivation is more concerned with the role of various elements including shedding lingering viral RNA for a prolonged time and incomplete resolution of infection along with the insight of dormant viral exosomes’ role. The concept of testing positive after two consecutive negative results requires proper discrimination of reinfection from reactivation. In this review, we summarized the current evidence for possible mechanisms leading to viral reactivation or test re-positivity. We also pointed out risk factors associated with both reinfection and reactivation. Future Medicine Ltd 2022-09-26 2022-09 /pmc/articles/PMC9514089/ /pubmed/36176508 http://dx.doi.org/10.2217/fvl-2021-0212 Text en © 2022 Future Medicine Ltd https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Review
Dowran, Razieh
Damavandi, Amirmasoud Rayati
Azad, Talat Mokhtari
Reinfection and reactivation of SARS-CoV-2
title Reinfection and reactivation of SARS-CoV-2
title_full Reinfection and reactivation of SARS-CoV-2
title_fullStr Reinfection and reactivation of SARS-CoV-2
title_full_unstemmed Reinfection and reactivation of SARS-CoV-2
title_short Reinfection and reactivation of SARS-CoV-2
title_sort reinfection and reactivation of sars-cov-2
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514089/
https://www.ncbi.nlm.nih.gov/pubmed/36176508
http://dx.doi.org/10.2217/fvl-2021-0212
work_keys_str_mv AT dowranrazieh reinfectionandreactivationofsarscov2
AT damavandiamirmasoudrayati reinfectionandreactivationofsarscov2
AT azadtalatmokhtari reinfectionandreactivationofsarscov2